Francois Bertelli
VP ADC development at DISCO Pharmaceuticals GmbH @ DISCO Pharmaceuticals GmbH
About
Expert in antibody drug conjugates (ADC) and bispecifics design, molecular modelling, production and characterisation. Pre-clinical in vitro/in vivo project management for mAbs, ADCs, Bispecifics, and T-cell recruitment in Oncology and Immuno-Oncology. Antibody format generation and humanisation, Antigen cloning, expression, purification and characterisation (All analytical methods and Biacore kinetics determination). CMC Management of upstream and downstream Process Characterisation and Validation of Antibody/Antigen (Mammalian Cell culture and Fermentation) for manufacturing using cGMP methods. Work closely with CRO/CMOs for process development. As part of the Technical Operations team for Rare Reagents production and purification, I evaluate and improve the processes for large-scale protein production such as Monoclonal antibodies (Hollow-fiber, perfusion, wavebags, spinners) and the purification processes (Chromatography, Ultrafiltration, Dialysis, TFF). Supporting the Process Validation projects, making sure that activities are compliant with QMS and external guidelines (FDA & EU). * Facilitate risk assessment/FMEA process. * Perform QMS maintenance activities and implement quality improvement activities. * Assures the accuracy and correctness of documentation used during process validation activities. * Provide GMP guidance. 15 years experience in Assay Development and High-Throughput-Screening Project Management. I have a track record in prosecution of drug discovery programmes from idea to candidate nomination, across broad disease, target and physiological systems. I have experience of both leading teams directly and indirectly through matrix-based disciplines Broad knowledge of most of the therapeutic areas for which several HTS campaigns have been run successfully. I have received the project management foundation certficate PRINCE2. Specialties: Pharmacology, Enzymology, Cell-based assays, kinase and Protein-Protein Interaction assays. Project Management Drug Discovery. Protein Charaterisation.
United Kingdom
Canterbury
Biotechnology
Drug Discovery, Assay Development, High Throughput Screening, Pharmacology, Lead Change, GPCRs, Purification, Medicinal Chemistry, Project Portfolio Management, Cell, Antibodies, HTS, Project Coordination, Biochemistry, Cell Culture, Cell Based Assays, Laboratory Automation, Clinical Development, Monoclonal Antibodies, Biomarkers
Experience

Head of Platform Development
Avvinity Therapeutics Limited

Drug Discovery Consultant
Dr. Francois BERTELLI
Canterbury, United Kingdom

Senior Principal Scientist
Sandwich UK
Team Leader in the High-Throughput-Screening Centre of Emphasis. Responsible for the prosecution of Pfizer global exploratory portfolio from assay development to lead optimization. Scientific liaison for Anti-infectives, Pain and CNS therapeutic areas, specialized in GPCR and Ion Channel Allosteric assay design. Managing daily interactions with global external CROs.

Group Leader
working on key therapeutic areas such as Pain and Inflammation. Implementing new technologies such as Peptide Phage Display, Surface Plasmon Resonance (Biacore) and large-scale fermentor Baculovirus protein production. Responsible for the Monoclonal Antibody production unit from Immunisation to large-scale antibody purification.
Francois Bertelli's Contact Information
Phone
Find the Right Leads
Find Verified Contact Data
What LeadContact does well
Find verified emails, phone numbers, and decision-makers with 98% accuracy.
Find Leads
Find the right people by company, role, industry, location, and more.
925M+ professional profiles

Find Emails
Access verified email addresses for your target contacts.
657M+ emails

Find Phone Numbers
Get cross-validated phone data from multiple top sources.
239M+ phone numbers

More Accurate. Lower Cost.
Find contact data in 1 tool with 98% accuracy
LeadContact integrates leading enrichment tools to deliver more accurate contact data—without paying for each one.
Great conversations start with the right contact.
It’s time to find yours.









